Since the mid-2000s, type I interferon (IFN)-stimulated genes (ISGs), such as MX1, also known as myxovirus resistance A (MxA), have been found to be upregulated in the muscle and skin of clinically diagnosed DM patients, indicating their involvement in DM pathophysiology (31–34). Here, MX1 is linked to diabetes mellitus.